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We aimed to explore the cross-country variation in the prevalence of comorbid prediabetes or diabetes and determine the
sociodemographic, lifestyle, and clinical factors, especially body mass index (BMI) and waist circumference, associated with
comorbid diabetes in individuals with hypertension in rural South Asia. We analyzed cross-sectional data of 2426 hypertensive
individuals of ≥40 years from 30 randomly selected rural communities in Bangladesh, Pakistan, and Sri Lanka. Prediabetes was
defined as fasting plasma glucose (FPG) between 100 and 125mg/dL without use of antidiabetic treatment and diabetes as FPG≥126mg/dL or use of antidiabetic medication. 0e prevalence (95% CI) of prediabetes or diabetes (53.5% (51.5%, 55.5%)) and
diabetes (27.7% (25.9%, 29.5%)) was high in the overall hypertensive study population in rural communities in 3 countries. Rural
communities in Sri Lanka had the highest crude prevalence of prediabetes or diabetes and diabetes (73.1% and 39.3%) with
hypertension, followed by those in Bangladesh (47.4% and 23.1%) and Pakistan (39.2% and 20.5%). 0e factors independently
associated with comorbid diabetes and hypertension were residing in rural communities in Sri Lanka, higher education, in-
ternational wealth index, waist circumference, pulse pressure, triglyceride, and lower high-density lipoprotein. 0e association of
diabetes with waist circumference was stronger than with BMI in hypertensive individuals. Prediabetes or diabetes are alarmingly
common among adults with hypertension and vary among countries in rural South Asia. 0e high prevalence of comorbid
diabetes in Sri Lanka among hypertensives is not fully explained by conventional risk factors and needs further etiological
research. Urgent public health efforts are needed to integrate diabetes control within hypertension management programs in rural
South Asia, including screening waist circumference.
1. Introduction
Diabetes is a major global public health concern and a
common comorbidity in individuals with hypertension
[1, 2]. About 425 million people had diabetes worldwide in
2017, and this number is expected to increase to 629 million
by 2045 [3]. 0e excess costs due to diabetes on healthcare
systems alone are tremendous, primarily due to the grave
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consequences of microvascular and macrovascular com-
plications (e.g., blindness, cardiovascular disease, myocar-
dial infarction, stroke, and kidney failure) [2, 3]. 0e
International Diabetes Federation estimated the global
health expenditure on diabetes was 850 billion in 2017 [3].
Of all the individuals with diabetes worldwide, approxi-
mately 80% live in low- and middle-income countries [3].
South Asian countries have an increasing burden of
diabetes [1, 4], with the estimated number of diabetic pa-
tients increasing from 58.7 million in 2010 to 101 million in
2030 [1]. 0e International Diabetes Foundation estimated
diabetes-related healthcare expenditure in 2017 to be ap-
proximately US $9.5 billion in the South Asian region [3].
0e rising burden could be related to increased life expec-
tancy, rapid population growth, unplanned urbanization,
and limited healthcare expenditure [5].
Studies in the West have consistently shown that type 2
diabetes is more common in South Asian immigrants than
other ethnic groups [6–9]. Moreover, prediabetes tends to
progress faster to diabetes in South Asians, at an earlier age
than in Europeans [10]. Diabetes is also associated with
greater risk of retinal and cerebral microvascular disease in
South Asians than Europeans [11, 12]. 0e susceptibility of
South Asians to dysglycemia has been shown to be apparent
since early childhood and is associated with low birth weight
and adverse in utero environment due to poor maternal
nutrition, followed by excessive relative weight gain during
childhood that persists into adulthood [13].
A high prevalence of diabetes has been reported in urban
South Asia and has been associated with sedentary lifestyle
and greater consumption of fast food rich in sugar and
saturated fats associated with progressive social, cultural,
and economic globalization [14, 15]. However, health sys-
tems are weaker, and complications from diabetes have
worse outcomes in rural than in urban areas [16].
Diabetes frequently coexists with hypertension and re-
portedly affects 7.5% to 32% hypertensive individuals [17–
23]. Studies of people with hypertension [19, 20, 23–26]
identified similar risk factors for diabetes to those in general
population [27, 28] such as demographical factors (older age
and male gender), unhealthy life style (smoking and physical
inactive), and clinical factors (overweight or central obesity
and dyslipidemia). However, there is a dearth of studies
comparing cross-country prevalence and determinants of
diabetes among hypertensive individuals living in rural
South Asia.
We analyzed baseline data from the ongoing COBRA-
BPS (Control of Blood Pressure (BP) and Risk Attenuation-
Bangladesh, Pakistan, and Sri Lanka) trial on 2426 hyper-
tensive individuals, to examine the prevalence and cross-
country differences in comorbid prediabetes and/or diabetes
in hypertensive individuals in rural communities in 3 South
Asian countries [29]. We aimed to determine whether the
sociodemographic characteristics, lifestyle factors, obesity,
and other clinical risk factors accounted for potential dif-
ferences in prevalence of comorbid diabetes among in-
dividuals with hypertension in rural areas across the 3 South
Asian countries. We also sought to determine whether
central or generalized obesity was a stronger determinant of
comorbid diabetes and hypertension. As an ancillary aim, we
compared the awareness and management of diabetes in the
3 countries.
We hypothesized that (1) the prevalence of comorbid
prediabetes or diabetes is high and varies among hyper-
tensive individuals in rural communities across the three
South Asian countries; (2) the cross-country variation in
comorbid diabetes and hypertension will only partially be
accounted for by differences in sociodemographic, lifestyle,
and cardiovascular risk factors; and (3) waist circumfer-
ence will be more strongly associated with comorbid di-
abetes and hypertension compared to body mass index
(BMI).
2. Methods
2.1. Population. 0e present study was performed using
baseline data from COBRA-BPS full-scale study. 0e de-
tailed information on the study has been described earlier
[29]. Briefly, COBRA-BPS full-scale study is an ongoing two-
year cluster randomized controlled trial among 2643 hy-
pertensive adults from 30 randomly selected rural clusters
(communities), 10 clusters each, in Bangladesh, Pakistan,
and Sri Lanka. In each country, cluster selection was
stratified by distance (≤2.5 km for near and >2.5 for far)
from the government primary care clinics, such that there
were 6 near and 4 far clusters in each country. Individuals in
each cluster were screened using door-to-door sampling
method. 0e inclusion criteria for COBRA-BPS were age≥40 years, hypertension (defined as sustained elevation of
systolic blood pressure (SBP) to ≥140mmHg, or diastolic
blood pressure (DBP) to ≥90mmHg based on two readings
from 2 separate days, or receiving antihypertensive medi-
cations), and residents in the selected clusters. Individuals
were excluded if they had severe physical incapacity, were
pregnant, had advanced diseases (on dialysis, liver failure,
and other systemic diseases), or were mentally comprised
leading to incapability of giving consent.
Supplementary Figure S1 shows the study flow diagram.
Of the 2977 hypertensive individuals from 30 randomly
selected clusters in 3 countries, 2643 were enrolled in the
clinical trial after excluding 334 individuals for various
reasons (Supplementary Figure S1). Of the 2643 hyperten-
sives recruited, 217 (9.3%) were excluded because they
missed laboratory data on fasting blood glucose and were
not on antidiabetic medication. 0e study protocol was
approved by respective Ethical Review Committee in Sin-
gapore, Bangladesh, Pakistan, Sri Lanka, and UK. All study
participants provided written informed consent.
2.2. Measurements. Self-reported sociodemographic and
economic status (age, gender, education, marital status,
international wealth index (IWI) [30]), lifestyle character-
istics (smoking and physical activity), cardiovascular disease
(CVD) (self-reported heart disease or stroke), and current
medication use were obtained at the baseline visit. Physical
activity was evaluated by the short version of the In-
ternational Physical Activity Questionnaire (IPAQ) [31].
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Framingham CVD risk score was computed, and ≥20%
indicated a high global CVD risk at 10 years [32].
An overnight fasting blood sample was collected to
measure lipids, serum creatinine, and plasma glucose
(measured on Roche Hitachi-Cobas c311 in Bangladesh,
Siemens ADVIA 1800 in Pakistan, and Beckman Coulter in
Sri Lanka). Urine albumin and creatinine excretion were
measured on spot urine samples by nephelometry using the
array systems method on the same equipment as for blood
tests in each country. All tests were done in an accredited
laboratory in each country. Glomerular filtration rate (GFR)
was estimated using the original Chronic Kidney Disease
Epidemiology Collaboration (CKD-EPI) equation [33].
Urine albumin and creatinine ratio (UACR) was determined
by urine albumin divided by urine creatinine. Chronic
kidney disease was defined as the presence of estimated
glomerular filtration rate (eGFR) ≤60ml/min/1.73m2 or
UACR ≥30mg/g.
On enrolment, participants’ weight, height, waist cir-
cumference, and BP were measured. BMI was calculated as
weight (in kilogram)/height (in meters2). BP was measured
four times every 5minutes of rest in sitting position using an
Omron HEM-7300 digital monitor. 0e mean of last 2
readings was used in the analysis. Pulse pressure (PP) was
calculated as the difference between SBP and DBP.
2.3. Analysis Methods. 0e main outcome was diabetes
defined as a fasting plasma glucose (FPG) ≥126mg/dL or
self-reported use of antidiabetic medication. Prediabetes was
defined as an FPG between 100 and 125mg/dL and not on
antidiabetic treatment.
Comparison of characteristics between hypertensive
individuals with and without comorbid diabetes was per-
formed using t-test for continuous variables and chi-square
test for categorical variables. When continuous variables
were not normally distributed, the Mann–Whitney U test
was used. Age- and gender-standardized prevalence of
comorbid prediabetes or diabetes with hypertension and
only comorbid diabetes with hypertension was computed
using direct standardization, with the standards being the
age (grouped as 40∼50, 50∼60, 60∼70, and ≥70 years) and
gender distribution of the total population. In addition, we
examined the distribution of central obesity (waist cir-
cumference: ≥90 cm for male and ≥80 cm for female) [34]
and categorical BMI (grouped as underweight or normal
(<23.0 kg/m2) vs. overweight or generalized obesity
(≥23.0 kg/m2)) [35] for hypertensive individuals with pre-
diabetes or diabetes, and only diabetes.
We performed logistic regression analysis to evaluate the
association between risk factors and comorbid diabetes in
the entire sample of hypertensive individuals from 3
countries, allowing for within-cluster correlation. Covariates
were chosen for the analysis if they were reported to be risk
factors for diabetes in previous studies or were associated
with diabetes based on standard logistic regression ignoring
clustering effects. Covariates in the initial standard logistic
regression model were country, socioeconomic variables
(age, gender, education, marital status, and IWI), smoking,
physical activity, BMI, waist circumference, PP, high-density
lipoprotein (HDL), and triglycerides. We used stepwise
method to select covariates with a significant level of 0.15 for
retaining variables and of 0.10 for removing a variable.
Country, education level, IWI, waist circumference, PP,
HDL, and triglyceride were selected. We also retained all the
excluded variables for final analysis because they were found
to be risk factors for diabetes in previous studies
[20, 25, 27, 28, 36].
Four models were constructed with these covariates. In
model 1, only country was included; in model 2, we further
introduced socioeconomic variables (age, gender, education,
marital status, and IWI) and BMI (grouped as <18.5,
18.5∼23.0, 23.0∼27.5, and ≥27.5 kg/m2) [35]; model 3 further
included waist circumference (grouped via gender-specific
quartiles: for male ≤82, 82∼91, 91∼98, and ≥98 cm and for
female ≤79, 79∼88, 88∼95, and ≥95 cm); and the final model
was adjusted for the variables in model 3 plus smoking,
physical activity (grouped via tertiles: <1381, 1381∼5544,
and ≥5544 MET-min/week), PP, HDL, and triglycerides. All
the models included cluster-specific random intercepts to
account for within-cluster correlation.
We also investigated two-way interactions of country
and gender with other variables to assess the presence of
country- or gender-specific effect, respectively. Significant
interactions were interpreted by the ratio of odds ratios
(ROR) [37] and subgroup analysis. Finally, we computed the
proportion (95% CI) of diabetic individuals with hyper-
tension who (1) were aware of their diabetes status defined as
self-reported doctor diagnosis of diabetes, (2) controlled BP
to conventional target of <140/90mmHg, (3) were receiving
statin therapy, and (4) were receiving antidiabetic medica-
tions (number and different classes). All analyses were
conducted using SAS version 9.4, and all hypothesis testing
was 2-tailed with P< 0.05 set as statistically significant.
3. Results
3.1. Characteristics of Participants. Of all the 2643 in-
dividuals with hypertension, 2426 (91.8%) were included in
the study. 0e mean age (±SD) of the participants was 58.8
(±11.3) years, the mean (±SD) BMI was 24.8 (±5.0) kg/m2,
and the mean (±SD) waist circumference was 90.5 (±12.7)
cm for male and 87.1 (±12.9) for female (Table 1).
Compared with hypertensive individuals without
comorbid diabetes, those with comorbid diabetes were older,
had a higher education and wealth index score, lower level of
physical activity, and higher BMI, waist circumference, and
PP, and were more likely to be from Sri Lanka. Comorbid
diabetes was also positively associated with higher levels of
triglyceride, CVD, CKD, and a CVD risk of 20% or above
(Table 1). No significant association was found between
comorbid diabetes and other variables.
Compared with individuals included in the analysis
(n � 2426), those excluded (n � 217) were more likely from
Pakistan, had lower education and lower proportion of
married persons, and were at lower socioeconomic level and
more often physically inactive (Supplementary Table S1).
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3.2. Prevalence of Comorbid Prediabetes or Diabetes and
Comorbid Diabetes with Hypertension Stratified by Country.
Table 2 summarizes the crude, and age- and gender-
standardized prevalence (95% CI) of comorbid pre-
diabetes or diabetes, and comorbid diabetes in the overall
rural hypertensive sample and by each country. 0e crude
prevalence (95% CI) of comorbid prediabetes or diabetes
among hypertensive individuals was 73.1% (70.0%, 76.2%) in
Sri Lanka, 47.4% (44.0%, 50.7%) in Bangladesh, and 39.2%
(35.6%, 42.8%) in Pakistan.
Likewise, comorbid diabetes was themost prevalent among
hypertensives in Sri Lanka (39.3% (35.9%, 42.7%)), followed by
Bangladesh (23.1% (20.2%, 25.9%)), and then Pakistan (20.5%
(17.6%, 23.5%)), with almost no change in prevalence after
adjustment for confounding by age and gender.
Supplementary Tables S2 and S3 report baseline char-
acteristics by country and by comorbid diabetes status in
each country, respectively.
3.3. BMI, Central Obesity, Comorbid Prediabetes or Diabetes
and Hypertension. Of all the hypertensive individuals with
comorbid prediabetes or diabetes, 71.5% (n � 915) were
overweight or had generalized obesity; 75.8% (n � 981) were
centrally obese; and 65.1% (n � 833) were both overweight/
generalized obesity plus central obesity. Of all the hyper-
tensive individuals with comorbid diabetes, 74.9% (n � 492)
were overweight or had generalized obesity; 82.4% (n � 552)
were centrally obese; and 70.3% (n � 462) were both
overweight/generalized obesity plus central obesity (data not
shown in the table).
3.4. Risk Factors for Comorbid Diabetes and Hypertension.
0e factors associated with comorbid diabetes in multi-
variable models are shown in Table 3. In model 1, compared
with hypertensive individuals from rural areas in Pakistan,
those from rural Bangladesh had similar odds of comorbid
Table 1: Comparison of baseline characteristics between hypertensive individuals with and without diabetes in rural areas in Bangladesh,
Pakistan, and Sri Lanka (n � 2426).
Variables Total (n � 2426) Without diabetes (n � 1753) With diabetes (n � 673) P value
Age (y), mean (SD) 58.8 (11.3) 58.4 (11.6) 59.9 (10.5) 0.003
Men, n (%) 864 (35.6) 609 (34.7) 255 (37.9) 0.15
Formal education, n (%) (vs. no formal) 1466 (60.4) 959 (54.7) 507 (75.3) <0.001
Unmarried, n (%) (vs. married) 638 (26.3) 468 (26.7) 170 (25.3) 0.47
International wealth index, mean (SD) 58.8 (21.0) 56.1 (21.2) 66.2 (18.4) <0.001
Smoking, n (%) 249 (10.3) 193 (11.0) 56 (8.3) 0.052
Physical activity (MET-min/week), n (%) 0.001<1381 791 (33.0) 558 (32.2) 233 (35.0)
1381∼5544 810 (33.8) 562 (32.4) 248 (37.3)≥5544 798 (33.3) 614 (35.4) 184 (27.7)
BMI (kg/m2), mean (SD) 24.8 (5.0) 24.3 (5.1) 26.0 (4.7) <0.001
BMI (kg/m2), n (%) <0.001<18.5 214 (8.9) 194 (11.1) 20 (3.0)
18.5∼23 692 (28.8) 547 (31.3) 145 (22.1)
23∼27.5 890 (37.0) 617 (35.3) 273 (41.6)≥27.5 610 (25.4) 391 (22.4) 219 (33.3)
Waist circumference† (cm), mean (SD) 88.3 (12.9) 86.5 (12.8) 93.2 (11.9) <0.001
Waist circumference† (cm), n (%) <0.001≤Q1 570 (23.5) 506 (28.9) 64 (9.6)
Q1∼Q2 611 (25.2) 460 (26.3) 151 (22.5)
Q2∼Q3 584 (24.1) 380 (21.7) 204 (30.5)≥Q3 657 (27.1) 406 (23.2) 251 (37.5)
Systolic blood pressure (mmHg), mean (SD) 145.5 (21.6) 145.1 (21.9) 146.4 (20.9) 0.17
Diastolic blood pressure (mmHg), mean (SD) 88.2 (14.1) 88.5 (14.3) 87.5 (13.6) 0.09
Pulse pressure (mmHg), mean (SD) 57.2 (14.9) 56.6 (14.9) 59.0 (14.6) <0.001
HDL (mg/dL), mean (SD) 45.2 (13.1) 45.4 (13.3) 44.8 (12.4) 0.38
Triglyceride (mg/dL), median (IQR) 129.4 (94, 183.1) 126.1 (90.7, 177.8) 139.3 (102.1, 202.7) <0.001
Self-reported CVD, n (%) 554 (23.4) 361 (21.1) 193 (29.1) <0.001
CKD (stage 3 A1 or worse), n (%) 899 (38.3) 567 (33.1) 332 (52.5) <0.001
10-year FraminghamCVD risk score 20% ormore‡, n
(%) 1052 (44.0) 590 (33.7) 462 (72.1) <0.001
Country, n (%) <0.001
Bangladesh 872 (35.9) 671 (38.3) 201 (29.9)
Pakistan 740 (30.5) 588 (33.5) 152 (22.6)
Sri Lanka 814 (33.6) 494 (28.2) 320 (47.6)
0e number of missing values were 8 for international wealth index, 1 for smoking, 27 for physical activities, 20 for BMI, 4 for waist circumference, 34 for
HDL, 35 for triglyceride, 54 for self-reported CVD, 78 for CKD, and 35 for Framingham risk score. SD, standard deviation; Met, metabolic equivalent; BMI,
body mass index; HDL, high-density lipoprotein; IQR, interquartile range; CVD, cardiovascular disease; CKD, chronic kidney disease. †Gender-specific
quartiles were used: Q1, Q2, and Q3 were 79, 88, and 95 among female and 82, 91, and 98 among male. ‡10-year Framingham CVD risk was estimated based
on the sex-specific general CVD risk score sheets.
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diabetes (OR� 1.16, 95% CI (0.84, 1.61)), while those from
rural Sri Lanka had significantly greater odds of comorbid
diabetes (OR� 2.55, 95% CI (1.86, 3.49)). Adjustment for
sociodemographic and clinical factors in models 2, 3, and 4
did not alter the association.
BMI had a strong positive association with comorbid
diabetes in model 2, but this association became non-
significant with adjustment for waist circumference and
other covariates in models 3 and 4.
Significant interactions were detected between country
and marital status (P for interaction� 0.011), international
wealth index (P for interaction� 0.038), and HDL (P
interaction� 0.002), but no interaction with gender was
significant. Table 4 presents the results of multivariate
analysis stratified by countries. 0ere was a protective effect
of being unmarried (vs. married) on comorbid diabetes only
among hypertensives in rural Pakistan (OR� 0.44, 95% CI
(0.24, 0.82)) (Table 4). IWI had a stronger positive associ-
ation with comorbid diabetes in Pakistan (ROR� 1.47, 95%
(1.07, 2.01)) and Bangladesh (ROR� 1.36, 95% (0.99, 1.86))
than Sri Lanka (Supplementary Table S4), but no association
in Sri Lanka (Table 4). 0e inverse association between HDL
and comorbid diabetes was only observed in Sri Lanka
(OR� 0.80, 95% CI (0.73, 0.88)) (Table 4).
3.5. Awareness and Management of Comorbid Diabetes and
Hypertension. Of all the 673 individuals with comorbid
diabetes in hypertension, 74.3% knew that they had diabetes.
0e rates of awareness of comorbid diabetes were compa-
rable between Bangladesh (81.6%) and Sri Lanka (80.0%),
being much higher than that of Pakistan (52.6%). Only
32.8% controlled their BP under 140/90mmHg, and 23.8%
were on statin (Supplementary Table S5). About 69% of all
hypertensive individuals with comorbid diabetes were on
glucose-lowering medication, with the lowest prevalence in
Pakistan (46%) (Supplementary Table S6). Overall, 48.7% of
the hypertensive individuals with comorbid diabetes re-
ported using biguanides, with 35.3% in Bangladesh, 32.2% in
Pakistan, and 65% in Sri Lanka.
4. Discussion
Our analysis of data on 2426 hypertensive individuals from
30 randomly selected rural communities in Bangladesh,
Pakistan, and Sri Lanka revealed a strikingly high prevalence
of comorbid prediabetes or diabetes affecting 1 in 2 in
hypertensive adults in 3 countries, and this was much higher
in Sri Lanka (2 in 3 adults) than the other 2 countries. Similar
cross-country variation was observed in the prevalence of
comorbid diabetes with 1 in 4 hypertensive adults affected in
all 3 countries and at least 1 in 3 in Sri Lanka. Formal
education, higher IWI, higher waist circumference, elevated
PP, increased levels of triglyceride, and residing in rural Sri
Lanka (vs. in rural Pakistan), each, were significantly as-
sociated with higher odds of comorbid diabetes. Waist
circumference was a stronger determinant of comorbid
diabetes and hypertension than BMI. Higher HDL, by
contrast, was associated with lower odds of comorbid di-
abetes and hypertension. 0ese factors only partially
explained the higher prevalence of comorbid diabetes
among hypertensive individuals in rural Sri Lanka. Our
findings of an alarmingly high prevalence of prediabetes
and/or diabetes as a key comorbidity in individuals with
hypertension call for integrating diabetes care with hyper-
tension management program in rural areas in South Asia.
Such efforts must be complemented with population-wide
policy initiatives for reducing key risk factors especially
obesity.
To our knowledge, this is the first report of cross-country
comparison of prevalence of comorbid diabetes among rural
Table 2: Overall and country-specific prevalence of diabetes and/or prediabetes among individuals with hypertension in rural communities
in Bangladesh, Pakistan, and Sri Lanka (n � 2426).
Total (n � 2426) Bangladesh (n � 872) Pakistan (n � 740) Sri Lanka (n � 814)
Prediabetes or diabetes
Crude prevalence, n (%, 95% CI) 1298 (53.5 (51.5, 55.5)) 413 (47.4 (44.0, 50.7)) 290 (39.2 (35.6, 42.8)) 595 (73.1 (70.0, 76.2))
Age-standardized prevalence, %
(95% CI) — 47.4 (42.7, 52.1) 39.0 (34.4, 43.5) 72.3 (66.0, 78.6)
Age- and gender-standardized
prevalence, % (95% CI) — 47.7 (42.9, 52.5) 38.8 (34.3, 43.4) 72.2 (65.9, 78.6)
Prediabetes only
Crude prevalence, n (%, 95% CI) 625 (25.8 (24.0, 27.5)) 212 (24.3 (21.4, 27.2)) 138 (18.7 (15.8, 21.5)) 275 (33.8 (30.5, 37.1))
Age-standardized prevalence, %
(95% CI) — 24.1 (20.7, 27.4) 18.5 (15.4, 21.6) 34.9 (30.3, 39.4)
Age- and gender-standardized
prevalence, % (95% CI) — 24.2 (20.8, 27.6) 18.7 (15.5, 21.8) 34.4 (29.9, 38.9)
Diabetes only
Crude prevalence, n (%, 95% CI) 673 (27.7 (25.9, 29.5)) 201 (23.1 (20.2, 25.9)) 152 (20.5 (17.6, 23.5)) 320 (39.3 (35.9, 42.7))
Age-standardized prevalence, %
(95% CI) — 23.3 (20.0, 26.6) 20.5 (17.2, 23.8) 37.4 (33.0, 41.8)
Age- and gender-standardized
prevalence, % (95% CI) — 23.5 (20.2, 26.9) 20.2 (16.9, 23.4) 37.8 (33.3, 42.3)
95% CI, 95% confidence interval.
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community dwellers with hypertension in South Asian
countries using a common protocol. We found that adults
with hypertension in rural Sri Lanka were older, better
educated, more centrally obese and less physically active, had
higher socioeconomic status, and higher pulse pressure
compared to those in rural Pakistan or Bangladesh (Sup-
plementary Table S2). However, these risk factors could not
account for the higher prevalence of comorbid diabetes
among hypertensives in rural Sri Lanka compared to
Pakistan or Bangladesh. An earlier study of urban hyper-
tensive Pakistanis has shown that 27.6% had comorbid
diabetes, which is higher than our finding of rural hyper-
tensive Pakistanis (20.5%) and parallels that of all the three
countries combined (28%) [18]. Ethnic differences in di-
abetes prevalence have previously been suggested among
South Asian countries [9, 38–42]. Earlier studies of
Table 3: Factors associated with diabetes among individuals with hypertension in rural communities in Bangladesh, Pakistan, and Sri Lanka.
Model 1 (n � 2426) Model 2 (n � 2398) Model 3 (n � 2398) Model 4 (n � 2350)
OR (95% CI) Pvalue OR (95% CI)
P
value OR (95% CI)
P
value OR (95% CI)
P
value
Country <0.001 0.15 0.067 <0.001
Pakistan 1.00 1.00 1.00 1.00
Bangladesh 1.16 (0.84,1.61) 0.35
1.12 (0.85,
1.48) 0.41
1.21 (0.91,
1.61) 0.19
1.18 (0.85,
1.62) 0.31
Sri Lanka 2.55 (1.86,3.49) <0.001 1.37 (0.99,1.89) 0.057 1.48 (1.07,2.06) 0.021 2.32 (1.57,3.41) <0.001
Age (y, per 5 y increase) — — 1.10 (1.05,1.16) <0.001 1.10 (1.04,1.15) <0.001 1.05 (0.99,1.11) 0.090
Women (vs. men) — — 0.93 (0.74,1.16) 0.53
0.93 (0.74,
1.17) 0.53
0.96 (0.74,
1.23) 0.73
Formal education (vs. no formal
education) — —
1.47 (1.12,
1.92) 0.005
1.35 (1.03,
1.78) 0.028
1.35 (1.02,
1.78) 0.036
Unmarried (vs. married) — — 0.87 (0.67,1.13) 0.28
0.87 (0.67,
1.13) 0.30
0.83 (0.63,
1.08) 0.17
International wealth index (per SD
increase) — —
1.32 (1.17,
1.50) <0.001 1.30 (1.15,1.47) <0.001 1.30 (1.14,1.48) <0.001
BMI (kg/m2) — — <0.001 0.55 0.84<18.5 1.00 1.00 1.00
18.5∼23 2.29 (1.37,3.85) 0.002
1.49 (0.86,
2.58) 0.16
1.29 (0.74,
2.26) 0.37
23∼27.5 3.75 (2.25,6.23) <0.001 1.47 (0.81,2.67) 0.20 1.27 (0.69,2.33) 0.44≥27.5 4.78 (2.84,8.07) <0.001 1.53 (0.81,2.91) 0.19 1.31 (0.68,2.52) 0.42
Waist circumference† (cm) — — — — <0.001 <0.001<Q1 — — 1.00 1.00
Q1∼Q2 — — 2.14 (1.47,3.12) <0.001 1.97 (1.34,2.90) <0.001
Q2∼Q3 — — 3.45 (2.29,5.20) <0.001 3.01 (1.97,4.59) <0.001≥Q3 — — 3.76 (2.40,5.89) <0.001 3.47 (2.18,5.51) <0.001
Smoking (vs. no smoking) — — — — — — 0.78 (0.53,1.13) 0.19
Physical activity (MET-min/week) — — — — — — 0.096<1381 — — — — — — 1.00
1381–5544 — — — — — — 1.03 (0.80,1.32) 0.82≥5544 — — — — — — 0.79 (0.61,1.03) 0.083
Pulse pressure (mmHg, per 5mmHg
increase) — — — — — —
1.07 (1.03,
1.11) <0.001
HDL (mg/dL, per 5mg/dL increase) — — — — — — 0.90 (0.86,0.96) <0.001
Triglyceride (mg/dL, per 5mg/dL
increase) — — — — — —
1.01 (1.01,
1.02) <0.001
OR, odds ratio; 95% CI, 95% confidence interval; SD, standard deviation; MET, metabolic equivalent task; BMI, body mass index; HDL, high-density
lipoprotein. No interaction terms were included in the model. P trend for BMI was 0.68 and for waist circumference was <0.001 in model 4. †Gender-specific
quartiles were used: Q1, Q2, and Q3 were 79, 88, and 95 among female and 82, 91, and 98 among male.
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nationally representative samples of the general population
have found the prevalence of diabetes was 10.3% among Sri
Lankans [38], 9.7% among Bangladeshis [39], and 5.4%
among Pakistanis [40], respectively. Using cross-sectional
data of 1,122,771 immigrants aged ≥20 years from South
Asia living in Canada, a higher age- and gender-
standardized prevalence of diabetes has been reported in
the diaspora from Sri Lanka than those from Pakistan and
India [41]. In another study of 16,288 individuals aged 20
and above, higher prevalence of diabetes and prediabetes
was reported in Chennai (22.8% and 37.9%, respectively)
and Delhi (25.2% and 47.6%) than in Karachi (16.3% and
31.1%) [42]. A more recent study of 431,765 migrant South
Asians in Canada reported that the diabetes prevalence was
the highest in Sri Lankan immigrants (26.8%), followed by
those from Bangladesh (22.2%) and Pakistan (19.6%) [9]. It
is likely that some other unmeasured risk factors could
explain the higher prevalence of comorbid diabetes among
hypertensives in Sri Lanka. Decades of conflict from the civil
war ending in 2009 has been shown to have an emotional
and psychological impact with high rates of anxiety and
depression in individuals in Sri Lanka [43]. Epidemiological
studies have implicated psychological stresses such as de-
pression and early-life adversity as risk factors for diabetes
[44]. Psychological stress may affect the development of
diabetes through the release of catecholamines and gluco-
corticoids such as cortisol, resulting in increased hepatic
glucose output, decreased insulin secretion and sensitivity,
central accumulation of body fat, and inflammation, as well
as through its adverse effects on behaviors including diet,
physical activity, and adherence to medication [44, 45]. 0e
observed difference could also result from differential dis-
tribution of other unmeasured factors such as inflammatory
markers [46], unhealthy diet [28], family history of diabetes
[27], organochlorine pesticide [47], or their interaction in
this ethnic group. More etiological research is needed in Sri
Lanka to understand the higher risk of comorbid diabetes in
the population with hypertension. Nevertheless, our findings
of an alarmingly high prevalence of comorbid diabetes (at
least 1 in 4) in individuals with hypertension in communities
in rural South Asia underscore the need for screening all
adults with hypertension for diabetes and management of
the latter in the primary care settings.
It is worth noting that central obesity (waist circum-
ference) was a stronger determinant of comorbid diabetes
than overweight/generalized obesity (BMI) in the overall
population from 3 countries. Previous studies of hyper-
tensive Chinese have shown that both BMI and waist cir-
cumference were correlates of diabetes with comparable
strength of association [19, 23], but others reported similar
results to ours [48, 49]. Notwithstanding the cross-sectional
study design, our findings suggest the independent role of
central obesity in diabetes development. BMI reflects total
body mass, and waist circumference reflects abdominal
obesity, largely a reflection of visceral fat. Abdominal adi-
pose tissue has been shown to be metabolically active
Table 4: Factors associated with diabetes among individuals with hypertension in rural communities in Bangladesh, Pakistan, and Sri Lanka.
Bangladesh (n � 866) Pakistan (n � 706) Sri Lanka (n � 778)
OR (95% CI) P Value OR (95% CI) P Value OR (95% CI) P Value
Age (y, per 5 y increase) 1.10 (0.99, 1.21) 0.077 0.98 (0.88, 1.11) 0.78 1.04 (0.94, 1.15) 0.43
Women (vs. men) 1.26 (0.76, 2.10) 0.37 0.67 (0.40, 1.12) 0.13 0.86 (0.57, 1.28) 0.45
Formal education (vs. no formal education) 1.15 (0.76, 1.72) 0.51 1.02 (0.61, 1.73) 0.93 3.72 (1.18, 11.77) 0.026
Unmarried (vs. married) 1.19 (0.71, 2.01) 0.50 0.44 (0.24, 0.82) 0.010 0.86 (0.57, 1.29) 0.47
International wealth index (per SD increase) 1.42 (1.10, 1.84) 0.008 1.64 (1.27, 2.12) <0.001 1.03 (0.83, 1.28) 0.76
Smoking (vs. no smoking) 0.86 (0.44, 1.71) 0.67 1.02 (0.56, 1.87) 0.94 0.65 (0.29, 1.43) 0.28
Physical activity (MET-min/week) 0.81 0.30 0.043<1381 1.00 1.00 1.00
1381∼5544 1.10 (0.70, 1.75) 0.68 0.68 (0.39, 1.18) 0.17 1.08 (0.73, 1.60) 0.70≥5544 0.96 (0.57, 1.63) 0.88 0.74 (0.45, 1.23) 0.24 0.67 (0.44, 1.01) 0.056
BMI (kg/m2) 0.82 0.99 0.63<18.5 1.00 1.00 1.00
18.5∼23 1.50 (0.39, 5.75) 0.55 1.16 (0.40, 3.34) 0.78 1.49 (0.65, 3.45) 0.34
23∼27.5 1.69 (0.41, 7.05) 0.47 1.08 (0.35, 3.34) 0.89 1.18 (0.47, 2.98) 0.72≥27.5 1.42 (0.31, 6.59) 0.65 1.07 (0.33, 3.50) 0.91 1.29 (0.48, 3.52) 0.61
Waist circumference† (cm) 0.002 0.019 0.038<Q1 1.00 1.00 1.00
Q1∼Q2 2.50 (1.21, 5.14) 0.014 1.81 (0.72, 4.54) 0.21 1.81 (1.01, 3.25) 0.048
Q2∼Q3 4.60 (2.03, 10.42) <0.001 3.54 (1.38, 9.08) 0.009 2.38 (1.25, 4.52) 0.009≥Q3 6.01 (2.35, 15.43) <0.001 3.87 (1.46, 10.26) 0.007 2.72 (1.36, 5.43) 0.005
Pulse pressure (mmHg, per 5mmHg increase) 1.06 (0.98, 1.14) 0.15 1.16 (1.07, 1.26) <0.001 1.05 (0.99, 1.11) 0.090
HDL (mg/dL, per 5mg/dL increase) 1.01 (0.91, 1.12) 0.85 0.91 (0.81, 1.01) 0.088 0.80 (0.73, 0.88) <0.001
Triglyceride (mg/dL, per 5mg/dL increase) 1.02 (1.01, 1.03) 0.001 1.01 (1.00, 1.02) 0.011 1.01 (1.00, 1.02) 0.077
OR, odds ratio; 95% CI, 95% confidence interval; SD, standard deviation; MET, metabolic equivalent task; BMI, body mass index; HDL, high-density
lipoprotein. Adjusted ORs were reported based on the final model (model 4) in Table 3. P trend was 0.99 and <0.001 for BMI and waist circumference in
Bangladesh, respectively; P trend was 0.95 and 0.005 for BMI and waist circumference in Pakistan, respectively; and P trend was 0.99 and 0.007 for BMI and
waist circumference in Sri Lanka, respectively. †Gender-specific quartiles were used: Q1, Q2, and Q3 were 79, 88, and 95 among female and 82, 91, and 98
among male.
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especially when oxygenation patterns are dysfunctional
leading to pathogenesis of insulin resistance, and glucose
intolerance, which is associated with adverse cardiovascular
risk profile [50–52]. For a given BMI, South Asians have
higher amounts of abdominal adipose and are more insulin
resistant than Caucasians [53, 54]. Our findings underscore
the importance of including waist circumference as a risk
marker for diabetes perhaps even preferentially than BMI in
community screening programs in South Asian populations.
Our findings of the association between high tri-
glycerides and comorbid diabetes are also consistent with
evidence in other populations [26]. Recent post hoc analysis
of the Diabetes Prevention Program suggested benefit of
lowering triglyceride on reducing new-onset diabetes [55]. It
is interesting to note that comorbid diabetes was more
prevalent in individuals in the higher IWI strata. However,
higher prevalence of diabetes in higher socioeconomic status
has also been reported in previous studies in the region [56].
At the same time, it is important to highlight that even the
higher socioeconomic strata households in these rural
communities have low international purchasing power
parity [57]. 0us, financial access to quality treatment is
limited, and adverse outcomes of diabetes have been shown
to be prevalent across all socioeconomic strata in South Asia.
BP control and lipid-lowering are key for preventing
diabetes-related vascular complications [58, 59]. We found
that the vast majority of hypertensive adults with diabetes
had poor BP control (67%) using the conventional target of<140/90mmHg.0e American Diabetes Association (ADA)
2016 Standards of Medical Care in Diabetes Standards and
the National Institute for Health and Care Excellence
(NICE) guidelines recommend biguanides as first-line
glucose-lowering drug for all individuals with type 2 di-
abetes needing drug therapy [60, 61], and statins for all
patients aged ≥40 years with diabetes [61, 62]. However, we
observed that biguanides and statins were underprescribed
in all three countries, especially in Bangladesh and Pakistan.
Our findings underscore the urgent need for comprehensive
diabetes management program for all rural communities in
Sri Lanka, Bangladesh, Pakistan, and other South Asian
countries.
0e major strengths of our study are that we used a
uniform study design, door-to-door sampling of individuals,
random selection of clusters, consistent definition of vari-
ables and outcomes, and standardized study procedures in
all 3 countries. 0ere are several limitations. First, our study
is a cross-sectional study, precluding any cause-effect re-
lationship inference between risk factors and comorbid
diabetes. However, cross-sectional design is appropriate for
determining cross-country variation in prevalence of
comorbid diabetes and potential factors associated with the
variation which was our main objective. Second, we defined
diabetes using FBG only and did not complement with oral
glucose test or HbA1c test, possibly underestimating di-
abetes prevalence in our sample. However, venous FBG is
considered acceptable for diagnosis of diabetes in epide-
miological studies [39]. 0ird, information on some im-
portant factors such as family history of diabetes,
psychological stress, and exposure to pesticide was not
collected in the study. 0ese and other unmeasured factors
need to be evaluated in future studies. Fourth, chemistry
analyzers and reagents used for our laboratory tests were
different between the laboratories from each country.
However, all laboratories were accredited to international
standards (CAP accreditation for the laboratories in Ban-
gladesh and Pakistan, and Bio-Rad for Sri Lanka), mini-
mizing the cross-lab variation in these tests. Finally, our
sample consisted of hypertensive participants aged ≥40 years
sampled in a certain geographic location in each country.
Regional differences in the prevalence of diabetes have been
observed within a country in South Asia [4, 63, 64].
0erefore, the findings may not be generalizable to all the
rural population, especially those free of hypertension or
younger than 40 years in each country. However, the 30
clusters were randomly selected and were at least 7 km apart
and stratified by distance from government clinic in each
country ensuring a fair representation of varying access to
healthcare and minimizing selection bias. 0us, we believe
our findings are robust and generalizable to the regions
where our study was conducted.
In conclusion, the prevalence of comorbid diabetes and
prediabetes was alarmingly high among individuals with
hypertension in rural communities in Bangladesh, Pakistan,
and Sri Lanka. Formal education, higher IWI, higher waist
circumference, elevated PP, increased levels of triglyceride,
and lower HDL, each, were significantly associated with
higher odds of comorbid diabetes. In addition, the higher
prevalence of comorbid diabetes among hypertensives in
rural Sri Lanka (compared to Pakistan) could not be
explained by socioeconomic factors, lifestyle behaviors, or
cardiovascular risk factors. Waist circumference was a
stronger risk factor for comorbid diabetes than BMI.
Moreover, lack of awareness of comorbid diabetes, poor BP
control, and underprescription of statins and biguanides
were common in all three countries. Further research is
necessary to explore reasons for variation in the prevalence
of comorbid diabetes across the countries, especially the high
prevalence in rural Sri Lanka. Concerted efforts are needed
to develop and implement effective and customized public
health programs for prevention and management of
comorbid diabetes integrated with hypertension care in rural
South Asia.
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